Enveric Biosciences Inc (NASDAQ:ENVB) has a beta value of 0.87 and has seen 44.72 million shares traded in the recent trading session. The company, currently valued at $7.09M, closed the recent trade at $1.26 per share which meant it gained $0.16 on the day or 14.55% during that session. The ENVB stock price is -453.97% off its 52-week high price of $6.98 and 48.41% above the 52-week low of $0.65. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.38 million shares traded. The 3-month trading volume is 3.54 million shares.
Enveric Biosciences Inc (NASDAQ:ENVB) trade information
Sporting 14.55% in the green today, the stock has traded in the green over the last five days, when the ENVB stock price touched $1.26 or saw a rise of 32.62%. Year-to-date, Enveric Biosciences Inc shares have moved -3.08%, while the 5-day performance has seen it change 5.00%. Over the past 30 days, the shares of Enveric Biosciences Inc (NASDAQ:ENVB) have changed 51.62%. Short interest in the company has seen 95060.0 shares shorted with days to cover at 0.01.
Enveric Biosciences Inc (ENVB) estimates and forecasts
Figures show that Enveric Biosciences Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -45.69% over the past 6 months, with this year growth rate of 7.79%, compared to 12.40% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 43.60% and 48.20% for the next quarter.
ENVB Dividends
Enveric Biosciences Inc is expected to release its next earnings report between March 29 and April 02 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Enveric Biosciences Inc (NASDAQ:ENVB)’s Major holders
Insiders own 9.54% of the company shares, while shares held by institutions stand at 9.07% with a share float percentage of 10.02%. Investors are also buoyed by the number of investors in a company, with Enveric Biosciences Inc having a total of 16 institutions that hold shares in the company. The top two institutional holders are AdvisorShares Investments, LLC with over 0.1 million shares worth more than $0.34 million. As of Jun 29, 2023, AdvisorShares Investments, LLC held 4.60% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 29578.0 shares as of Jun 29, 2023. The firm’s total holdings are worth over $99677.0 and represent 1.36% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are AdvisorShares Trust-AdvisorShares Psychedelics ETF and Vanguard Extended Market Index Fund. As of Sep 29, 2023, the former fund manager holds about 6.73% shares in the company for having 0.15 million shares of worth $0.35 million while later fund manager owns 12515.0 shares of worth $42175.0 as of Jun 29, 2023, which makes it owner of about 0.57% of company’s outstanding stock.
